ERBB2 and breast cancer: The prognostic role of immune microenvironment in BC has been highlighted by numerous reports, demonstrating that tumor‐infiltrating lymphocytes (TILs) predict favorable disease outcome especially in the triple‐negative (TNBC) and HER2+ subtypes (Denkert et al., 2018).